Oncology & Cancer

Study supports PSA screening for male BRCA2 carriers

(HealthDay)—Systematic prostate-specific antigen (PSA) screening is advised for men who are carriers of the BRCA2 mutation, which is associated with a higher incidence of prostate cancer, younger age at diagnosis, and clinically ...

Oncology & Cancer

Thirty percent fewer prostate cancer deaths with PSA screening

PSA screening cuts deaths from prostate cancer by some 30 percent. This research was based on data of 20,000 men monitored for more than two decades. The men's initially measured PSA levels proved highly significant as a ...

Oncology & Cancer

One-off PSA screening for prostate cancer does not save lives

Inviting men with no symptoms to a one-off PSA test for prostate cancer does not save lives according to results from the largest ever prostate cancer trial conducted over 10 years by Cancer Research UK-funded scientists ...

Oncology & Cancer

Prostate cancer screening rates appear to level after recent drop

Declines in prostate specific antigen (PSA) testing that came after changes in government screening guidelines have abated in recent years, according to a new study. Writing in JAMA Internal Medicine, American Cancer Society ...

page 3 from 13